Skip to main content
NCBI home page
British Journal of Pharmacology logoLink to British Journal of Pharmacology
. 1993 Jun;109(2):322–329. doi: 10.1111/j.1476-5381.1993.tb13573.x

Mechanisms of vasodilatation in pregnancy: studies of the role of prostaglandins and nitric-oxide in changes of vascular reactivity in the in situ blood perfused mesentery of pregnant rats.

Z M Chu 1, L J Beilin 1
PMCID: PMC2175702  PMID: 8358537

Abstract

1. To examine the possible mechanisms of the vasodilatation and blunted pressor responses in late pregnancy, we have studied vascular reactivity of the in situ blood perfused mesenteric resistance vessels of 18-20 day pregnant Wistar-Kyoto rats (WKY). 2. Intra-arterial mean blood pressure (MBP) was lower in pregnant rats than in nonpregnant controls. There was no significant difference in basal mesenteric perfusion pressure (BPP) between groups. 3. Vascular reactivity to electrical stimulation (ES) or intra-arterial noradrenaline (NA), angiotensin II (AII) and arginine vasopressin (AVP) was decreased in the preparations from pregnant rats compared to that from nonpregnant controls. Noradrenaline spillover into mesenteric venous blood following ES was similar in pregnant and nonpregnant animals. 4. Indomethacin (5 mg kg-1, i.v.), an inhibitor of cyclo-oxygenase, induced significant increases in reactivity to ES in both pregnant and nonpregnant groups while potentiating the responses to NA and AII in nonpregnant animals only and having no effect on AVP-induced contractions in the preparations from either pregnant or nonpregnant animals. 5. NG-nitro-L-arginine (L-NOARG) (5 mg kg-1, i.v.), an inhibitor of nitric-oxide synthase, increased MBP and BPP in both pregnant and nonpregnant animals, but the difference in MBP between groups was still evident. 6. L-NOARG enhanced mesenteric vascular responses to ES, NA and AII in both pregnant and nonpregnant groups. Only the difference in NA responses between groups was abolished after pretreatment with L-NOARG. 7. These data show that vasoconstrictor responses to a variety of agonists are decreased in the in situ blood-perfused mesenteric resistance vessels of pregnant rats.(ABSTRACT TRUNCATED AT 250 WORDS)

Full text

PDF
322

Images in this article

326Figure 6
on p.326

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Assali N. S., Nuwayhid B., Brinkman C. R., 3rd, Tabsh K., Erkkola R., Ushioda E. Autonomic control of the pelvic circulation: in vivo and in vitro studies in pregnant and nonpregnant sheep. Am J Obstet Gynecol. 1981 Dec 15;141(8):873–884. doi: 10.1016/s0002-9378(16)32678-3. [DOI] [PubMed] [Google Scholar]
  2. Bay W. H., Ferris T. F. Factors controlling plasma renin and aldosterone during pregnancy. Hypertension. 1979 Jul-Aug;1(4):410–415. doi: 10.1161/01.hyp.1.4.410. [DOI] [PubMed] [Google Scholar]
  3. Beilin L. J., Deacon J., Michael C. A., Vandongen R., Lalor C. M., Barden A. E., Davidson L., Rouse I. Diurnal rhythms of blood pressure, plasma renin activity, angiotensin II and catecholamines in normotensive and hypertensive pregnancies. Clin Exp Hypertens B. 1983;2(2):271–293. doi: 10.3109/10641958309006086. [DOI] [PubMed] [Google Scholar]
  4. CHESLEY L. C., TALLEDO E., BOHLER C. S., ZUSPAN F. P. VASCULAR REACTIVITY TO ANGIOTENSIN II AND NOREPINEPHRINE IN PREGNANT WOMEN. Am J Obstet Gynecol. 1965 Mar 15;91:837–842. doi: 10.1016/0002-9378(65)90462-x. [DOI] [PubMed] [Google Scholar]
  5. Conrad K. P., Colpoys M. C. Evidence against the hypothesis that prostaglandins are the vasodepressor agents of pregnancy. Serial studies in chronically instrumented, conscious rats. J Clin Invest. 1986 Jan;77(1):236–245. doi: 10.1172/JCI112282. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Conrad K. P., Vernier K. A. Plasma level, urinary excretion, and metabolic production of cGMP during gestation in rats. Am J Physiol. 1989 Oct;257(4 Pt 2):R847–R853. doi: 10.1152/ajpregu.1989.257.4.R847. [DOI] [PubMed] [Google Scholar]
  7. Dogterom J., De Jong W. Diminished pressor response to noradrenaline of the perfused tail artery of pregnant rats. Eur J Pharmacol. 1974 Feb;25(2):267–269. doi: 10.1016/0014-2999(74)90062-4. [DOI] [PubMed] [Google Scholar]
  8. Everett R. B., Worley R. J., MacDonald P. C., Gant N. F. Effect of prostaglandin synthetase inhibitors on pressor response to angiotensin II in human pregnancy. J Clin Endocrinol Metab. 1978 Jun;46(6):1007–1010. doi: 10.1210/jcem-46-6-1007. [DOI] [PubMed] [Google Scholar]
  9. Gant N. F., Whalley P. J., Everett R. B., Worley R. J., MacDonald P. C. Control of vascular reactivity in pregnancy. Am J Kidney Dis. 1987 Apr;9(4):303–307. doi: 10.1016/s0272-6386(87)80126-9. [DOI] [PubMed] [Google Scholar]
  10. Goodman R. P., Killam A. P., Brash A. R., Branch R. A. Prostacyclin production during pregnancy: comparison of production during normal pregnancy and pregnancy complicated by hypertension. Am J Obstet Gynecol. 1982 Apr 1;142(7):817–822. doi: 10.1016/s0002-9378(16)32525-x. [DOI] [PubMed] [Google Scholar]
  11. Harrison G. L., Moore L. G. Blunted vasoreactivity in pregnant guinea pigs is not restored by meclofenamate. Am J Obstet Gynecol. 1989 Jan;160(1):258–264. doi: 10.1016/0002-9378(89)90132-4. [DOI] [PubMed] [Google Scholar]
  12. Hart J. L., Freas W., Muldoon S. M. Neurovascular function in the rat during pregnancy. Am J Physiol. 1986 Nov;251(5 Pt 2):H1000–H1008. doi: 10.1152/ajpheart.1986.251.5.H1000. [DOI] [PubMed] [Google Scholar]
  13. Humphreys P. W., Joels N. Reflex response of the rabbit hind-limb muscle vascular bed to baroreceptor stimulation and its modification by pregnancy. J Physiol. 1982 Sep;330:461–473. doi: 10.1113/jphysiol.1982.sp014352. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Humphreys P. W., Joels N. The response of the hind-limb vascular bed of the rabbit to sympathetic stimulation and its modification by pregnancy. J Physiol. 1982 Sep;330:475–488. doi: 10.1113/jphysiol.1982.sp014353. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Jackson E. K., Campbell W. B. The in situ blood perfused rat mesentery; a model for assessing modulation of adrenergic neurotransmission. Eur J Pharmacol. 1980 Aug 29;66(2-3):217–224. doi: 10.1016/0014-2999(80)90145-4. [DOI] [PubMed] [Google Scholar]
  16. Jansakul C., King R. G., Boura A. L. Effects of endothelial cell removal on alpha-adrenoceptor-mediated responses of aortae of pregnant rats. Clin Exp Pharmacol Physiol. 1990 Feb;17(2):147–156. doi: 10.1111/j.1440-1681.1990.tb01297.x. [DOI] [PubMed] [Google Scholar]
  17. Kawasaki H., Nuki C., Saito A., Takasaki K. Role of calcitonin gene-related peptide-containing nerves in the vascular adrenergic neurotransmission. J Pharmacol Exp Ther. 1990 Jan;252(1):403–409. [PubMed] [Google Scholar]
  18. Kawasaki H., Takasaki K., Saito A., Goto K. Calcitonin gene-related peptide acts as a novel vasodilator neurotransmitter in mesenteric resistance vessels of the rat. Nature. 1988 Sep 8;335(6186):164–167. doi: 10.1038/335164a0. [DOI] [PubMed] [Google Scholar]
  19. Mahoney D. P., Barden A., Beilin L. J., Vandongen R. Radioimmunoassay of prostaglandins and thromboxane B2 in extracted and unextracted urine and serum using an iodinated ligand. Prostaglandins Leukot Med. 1983 Sep;12(1):11–20. doi: 10.1016/0262-1746(83)90063-x. [DOI] [PubMed] [Google Scholar]
  20. Marshall J. M. Effects of ovarian steroids and pregnancy on adrenergic nerves of uterus and oviduct. Am J Physiol. 1981 May;240(5):C165–C174. doi: 10.1152/ajpcell.1981.240.5.C165. [DOI] [PubMed] [Google Scholar]
  21. Massicotte G., St-Louis J., Parent A., Schiffrin E. L. Decreased in vitro responses to vasoconstrictors during gestation in normotensive and spontaneously hypertensive rats. Can J Physiol Pharmacol. 1987 Dec;65(12):2466–2471. doi: 10.1139/y87-391. [DOI] [PubMed] [Google Scholar]
  22. Matthews J. N., Altman D. G., Campbell M. J., Royston P. Analysis of serial measurements in medical research. BMJ. 1990 Jan 27;300(6719):230–235. doi: 10.1136/bmj.300.6719.230. [DOI] [PMC free article] [PubMed] [Google Scholar]
  23. Molnár M., Hertelendy F. N omega-nitro-L-arginine, an inhibitor of nitric oxide synthesis, increases blood pressure in rats and reverses the pregnancy-induced refractoriness to vasopressor agents. Am J Obstet Gynecol. 1992 May;166(5):1560–1567. doi: 10.1016/0002-9378(92)91634-m. [DOI] [PubMed] [Google Scholar]
  24. Myers P. R., Guerra R., Jr, Harrison D. G. Release of NO and EDRF from cultured bovine aortic endothelial cells. Am J Physiol. 1989 Apr;256(4 Pt 2):H1030–H1037. doi: 10.1152/ajpheart.1989.256.4.H1030. [DOI] [PubMed] [Google Scholar]
  25. Paller M. S., Gregorini G., Ferris T. F. Pressor responsiveness in pseudopregnant and pregnant rats: role of maternal factors. Am J Physiol. 1989 Oct;257(4 Pt 2):R866–R871. doi: 10.1152/ajpregu.1989.257.4.R866. [DOI] [PubMed] [Google Scholar]
  26. Paller M. S. Mechanism of decreased pressor responsiveness to ANG II, NE, and vasopressin in pregnant rats. Am J Physiol. 1984 Jul;247(1 Pt 2):H100–H108. doi: 10.1152/ajpheart.1984.247.1.H100. [DOI] [PubMed] [Google Scholar]
  27. Palmer R. M., Ferrige A. G., Moncada S. Nitric oxide release accounts for the biological activity of endothelium-derived relaxing factor. Nature. 1987 Jun 11;327(6122):524–526. doi: 10.1038/327524a0. [DOI] [PubMed] [Google Scholar]
  28. Pan Z. R., Lindheimer M. D., Bailin J., Barron W. M. Regulation of blood pressure in pregnancy: pressor system blockade and stimulation. Am J Physiol. 1990 May;258(5 Pt 2):H1559–H1572. doi: 10.1152/ajpheart.1990.258.5.H1559. [DOI] [PubMed] [Google Scholar]
  29. Parent A., Schiffrin E. L., St-Louis J. Role of the endothelium in adrenergic responses of mesenteric artery rings of pregnant rats. Am J Obstet Gynecol. 1990 Jul;163(1 Pt 1):229–234. doi: 10.1016/s0002-9378(11)90703-0. [DOI] [PubMed] [Google Scholar]
  30. Umans J. G., Lindheimer M. D., Barron W. M. Pressor effect of endothelium-derived relaxing factor inhibition in conscious virgin and gravid rats. Am J Physiol. 1990 Aug;259(2 Pt 2):F293–F296. doi: 10.1152/ajprenal.1990.259.2.F293. [DOI] [PubMed] [Google Scholar]

Articles from British Journal of Pharmacology are provided here courtesy of The British Pharmacological Society

RESOURCES